참고문헌
- Algood HM, Chan J, Flynn JL. Chemokines and tuberculosis. Cytokine Growth Factor Rev. 2003. 14: 467-477. https://doi.org/10.1016/S1359-6101(03)00054-6
- Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas Re, Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis. 2003. 83: 98-106. https://doi.org/10.1016/S1472-9792(02)00054-9
- Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ, Yoon D, Lee MH, Kim DJ, Park M, Cha SH, Kim JW, Han BG, Min H, Ahn Y, Park MS, Han HR, Jang HY, Cho EY, Lee JE, Cho NH, Shin C, Park T, Park JW, Lee JK, Cardon L, Clarke G, McCarthy MI, Lee JY, Lee JK, Oh B, Kim HL. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009. 41: 527-534. https://doi.org/10.1038/ng.357
-
Du G, Chen CY, Shen Y, Qiu L, Huang D, Wang R, Chen ZW. TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific
$CD4^+$ and$CD8^+$ T effector cells in immunity against tuberculosis. J Immunol. 2010. 185: 3940-3947. https://doi.org/10.4049/jimmunol.1001222 -
Ersek B, Molnar V, Balogh A, Matko J, Cope AP, Buzas EI, Falus A, Nagy G.
$CD3{\zeta}$ -Chain Expression of Human T Lymphocytes Is Regulated by TNF via Src-like Adaptor Protein-Dependent Proteasomal Degradation. J Immunol. 2012. 189: 1602-1610. https://doi.org/10.4049/jimmunol.1102365 - Fogel N. Tuberculosis: a disease without boundaries. Tuberculosis. 2015. 95: 527-531. https://doi.org/10.1016/j.tube.2015.05.017
- Guy CS, Vignali DA. Organization of proximal signal initiation at the TCR:CD3 complex. Immunol Rev. 2009. 232: 7-21. https://doi.org/10.1111/j.1600-065X.2009.00843.x
- Harishankar M, Selvaraj P, Bethunaickan R. Influence of Genetic Polymorphism Towards Pulmonary Tuberculosis Susceptibility. Front Med. 2018. 5: 213. https://doi.org/10.3389/fmed.2018.00213
- HIRA. Health Insurance Review & Assessment Service. http://gisopendata.hira.or.kr/map.do.
- Jin HS, Park S. Association of the CD226 Genetic Polymorphisms with Risk of Tuberculosis. Biomedical Science Letters. 2017. 23: 89-95. https://doi.org/10.15616/BSL.2017.23.2.89
- Min J, Kim JS, Kim HW, Shin AY, Koo HK, Lee SS, Kim YK, Shin KC, Chang JH, Chun G, Lee J, Park MS, Park JS. Clinical profiles of early and tuberculosis-related mortality in South Korea between 2015 and 2017: a cross-sectional study. BMC Infect Dis. 2019. 19: 735. https://doi.org/10.1186/s12879-019-4365-9
- Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, Mulenga H, Hanekom WA, Self SG, Bekker LG, Ryall R, Gurunathan S, DiazGranados CA, Andersen P, Kromann I, Evans T, Ellis RD, Landry B, Hokey DA, Hopkins R, Ginsberg AM, Scriba TJ, Hatherill M. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination. N Engl J Med. 2018. 379: 138-149. https://doi.org/10.1056/NEJMoa1714021
- Rieux-Laucat F, Hivroz C, Lim A, Mateo V, Pellier I, Selz F, Fischer A, Le Deist F. Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N Engl J Med. 2006. 354: 1913-1921. https://doi.org/10.1056/NEJMoa053750
-
Seitzer U, Kayser K, Hohn H, Wacker HH, Ploetz S, Flad HD, Gerdes J, Maeurer MJ. Reduced T-cell receptor
$CD3{\zeta}$ -chain protein and sustained$CD3{\varepsilon}$ expression at the site of mycobacterial infection. Immunology. 2001. 104: 269-277. https://doi.org/10.1046/j.1365-2567.2001.01323.x - Zhang C, Liu J, Zhong JF, Zhang X. Engineering CAR-T cells. Biomark Res. 2017. 5: 22. https://doi.org/10.1186/s40364-017-0102-y